MeSH tree: D12.776.124.790.651.114.224.060
University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung cancer and better monitoring of treatment.
Mar 6, 2025
0
20
Researchers at the Icahn School of Medicine at Mount Sinai have made an important discovery that could help doctors choose better treatments for patients with recurrent endometrial cancer. Their study, published in the Journal ...
Mar 4, 2025
0
29
A simple treatment algorithm may help reduce treatment disparities for Hispanic and Black people with multiple sclerosis (MS), according to a preliminary study released today, March 3, 2025, that will be presented at the ...
Mar 3, 2025
0
11
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy (OIT) in people with allergic reactions to very small amounts of common food ...
Mar 2, 2025
0
34
A comprehensive study of effective responses as well as resistant responses to a kidney cancer anti-PD-1 therapy found specific immune features that could provide new targets to improve cancer treatment, say findings published ...
Feb 28, 2025
0
29
Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer Research Center (DKFZ) and the Heidelberg Institute for Stem Cell Technology and Experimental Medicine ...
Feb 17, 2025
0
63
Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for scientists. T cells, which are the frontline warriors in the battle against infections, have been a ...
Feb 12, 2025
0
15
A study by Michigan Medicine researchers has investigated possible genetic factors for drug efficacy for children with Crohn's disease.
Feb 10, 2025
0
14
A team led by the Institute for Bioengineering of Catalonia (IBEC) and the Hospital del Mar Research Institute has developed the MIRO (Micro Immune Response On chip), a device that allows researchers to replicate the characteristics ...
Feb 6, 2025
0
28
The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.
Feb 6, 2025
0
18
